title: Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis.
authors.affiliation: Hôpital Lapeyronie, Montpellier, France.
authors.forename: M -J
authors.initials: M-
authors.lastname: Kaiser
authors.forename: M -C
authors.initials: M-
authors.lastname: Bozonnat
authors.forename: C
authors.initials: C
authors.lastname: Jorgensen
authors.forename: J -P
authors.initials: J-
authors.lastname: Daurès
authors.forename: J
authors.initials: J
authors.lastname: Sany
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D002648:Child; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D013717:Tenosynovitis / Q000188:drug therapy* / Q000473:pathology
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept